Il y a eu 50 transactions d'initiés récentes enregistrées pour Collegium Pharmaceutical, Inc. (COLL), dont 12 achats et 35 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $13.5M.
Les initiés notables ayant une activité récente comprennent Dieter David, Dreyer Scott, Karnani Vikram. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — COLL
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-18 |
Dieter David |
EVP & General Counsel |
Vente Informative |
13,976 |
$34.92 |
$488.1K |
77,071 |
| 2026-03-17 |
Dieter David |
EVP & General Counsel |
Retenue Fiscale RSU |
8,840 |
$35.72 |
$315.76K |
68,231 |
| 2026-03-03 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
3,559 |
$40.99 |
$145.88K |
71,770 |
| 2026-02-10 |
Karnani Vikram |
President and CEO |
Attribution de RSU |
79,264 |
- |
- |
176,629 |
| 2026-02-10 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Retenue Fiscale RSU |
21,615 |
$46.75 |
$1.01M |
121,746 |
| 2026-02-10 |
Smith Thomas B |
EVP and Chief Medical Officer |
Attribution de RSU |
14,268 |
- |
- |
85,312 |
| 2026-02-10 |
Tupper Colleen |
EVP & Chief Financial Officer |
Retenue Fiscale RSU |
26,679 |
$46.75 |
$1.25M |
147,282 |
| 2026-02-10 |
Dieter David |
EVP & General Counsel |
Attribution de RSU |
22,194 |
- |
- |
91,047 |
| 2025-12-08 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Exercice d'Options (Vente) |
17,600 |
$15.90 |
$279.84K |
- |
| 2025-12-05 |
Balice-gordon Rita J. |
Director |
Vente Informative |
3,650 |
$47.03 |
$171.67K |
52,629 |
| 2025-11-12 |
Fallon John A. |
Director |
Exercice d'Options (Vente) |
19,853 |
$9.33 |
$185.23K |
- |
| 2025-11-12 |
Karnani Vikram |
President and CEO |
Retenue Fiscale RSU |
8,983 |
$47.35 |
$425.35K |
96,989 |
| 2025-11-06 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
4,858 |
$41.28 |
$200.52K |
126,667 |
| 2025-08-29 |
Smith Thomas B |
EVP and Chief Medical Officer |
Vente Informative |
17,478 |
$38.42 |
$671.58K |
70,264 |
| 2025-08-18 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Exercice d'Options (Vente) |
16,389 |
$21.34 |
$349.74K |
- |
| 2025-08-15 |
Santini Gino |
Director |
Exercice d'Options (Vente) |
15,000 |
$13.45 |
$201.75K |
- |
| 2025-08-13 |
Rubric Capital Management Lp |
10 Percent Owner |
Vente Informative |
25,000 |
$37.85 |
$946.25K |
3,132,743 |
| 2025-08-13 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Exercice d'Options (Vente) |
4,861 |
$21.34 |
$103.73K |
16,389 |
| 2025-08-08 |
Freund John Gordon |
Director |
Vente Informative |
11,659 |
$34.36 |
$400.64K |
23,129 |
| 2025-08-07 |
Rubric Capital Management Lp |
10 Percent Owner |
Inconnu |
- |
- |
- |
3,157,743 |
| 2025-06-09 |
Freund John Gordon |
Director |
Exercice d'Options (Vente) |
15,000 |
$13.45 |
$201.75K |
- |
| 2025-05-15 |
Bohlin Garen G |
Director |
Attribution de RSU |
9,791 |
- |
- |
62,259 |
| 2025-05-15 |
Santini Gino |
Director |
Attribution de RSU |
9,791 |
- |
- |
85,447 |
| 2025-05-15 |
Freund John Gordon |
Director |
Attribution de RSU |
9,791 |
- |
- |
62,259 |
| 2025-05-15 |
Lurker Nancy |
Director |
Attribution de RSU |
9,791 |
- |
- |
22,517 |
| 2025-05-15 |
Fallon John A. |
Director |
Attribution de RSU |
9,791 |
- |
- |
64,634 |
| 2025-05-15 |
Paya Carlos V |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-05-15 |
Paya Carlos V |
Director |
Attribution de RSU |
19,582 |
- |
- |
19,582 |
| 2025-05-15 |
Balice-gordon Rita J. |
Director |
Attribution de RSU |
9,791 |
- |
- |
56,279 |
| 2025-03-21 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
18,881 |
$30.03 |
$566.98K |
103,613 |
| 2025-03-21 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
6,396 |
$30.03 |
$192.07K |
156,667 |
| 2025-03-20 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
1,927 |
$30.00 |
$57.81K |
122,494 |
| 2025-03-20 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
1,206 |
$30.00 |
$36.18K |
163,063 |
| 2025-03-17 |
Dieter David |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-17 |
Dieter David |
EVP & General Counsel |
Attribution de RSU |
68,449 |
- |
- |
68,449 |
| 2025-03-14 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
2,255 |
$30.00 |
$67.66K |
124,421 |
| 2025-03-14 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
977 |
$30.00 |
$29.31K |
164,269 |
| 2025-03-11 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
10,445 |
$30.01 |
$313.41K |
165,246 |
| 2025-03-11 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
15,387 |
$30.00 |
$461.67K |
126,676 |
| 2025-03-07 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
2,348 |
$30.00 |
$70.45K |
142,063 |
| 2025-03-07 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
1,504 |
$30.00 |
$45.12K |
175,691 |
| 2025-03-06 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Vente Informative |
26,067 |
$28.50 |
$742.95K |
108,137 |
| 2025-03-06 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
3,295 |
$30.00 |
$98.85K |
144,411 |
| 2025-03-06 |
Tupper Colleen |
EVP & Chief Financial Officer |
Vente Informative |
1,949 |
$30.00 |
$58.47K |
177,195 |
| 2025-03-06 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Vente Informative |
15,387 |
$30.00 |
$461.67K |
126,676 |
| 2025-03-05 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Vente Informative |
20,000 |
$28.03 |
$560.53K |
134,204 |
| 2025-03-04 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Exercice d'Options (Vente) |
40,000 |
$24.03 |
$961.2K |
- |
| 2025-02-10 |
Heffernan Michael Thomas |
Director |
Attribution de RSU |
4,820 |
- |
- |
50,328 |
| 2025-02-10 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Retenue Fiscale RSU |
25,149 |
$30.52 |
$767.55K |
154,204 |
| 2025-02-10 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Retenue Fiscale RSU |
21,670 |
$30.52 |
$661.37K |
147,706 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
